Filipa M D Costa, Sónia P V Martins, Emilia C T D Moreira, José C M S Cardoso, Lia P N S Fernandes
{"title":"心衰患者的焦虑及其与社会人口统计学和临床特征的关系:一项横断面研究。","authors":"Filipa M D Costa, Sónia P V Martins, Emilia C T D Moreira, José C M S Cardoso, Lia P N S Fernandes","doi":"10.1097/j.pbj.0000000000000177","DOIUrl":null,"url":null,"abstract":"<p><p>Anxiety is one of the most frequent psychiatric disorders in heart failure (HF) patients. However, it is often neglected in clinical practice and studies about the particular relationship with the New York Heart Association (NYHA) classes for HF are scarce. In this context, this study aims to analyze the presence of anxiety symptoms in HF outpatients and also its association with sociodemographic and clinical characteristics of these patients.</p><p><strong>Methods: </strong>This cross-sectional study is part of the longitudinal Deus Ex-Machina project (NORTE-01-0145-FEDER-000026). HF patients were recruited at an outpatient clinic at a University Hospital. Patients with inability to communicate, severe visual/hearing impairment, or NYHA class IV were excluded. Sociodemographic data and NYHA class were registered. Anxiety was assessed with the 7-item Generalized Anxiety Disorders Scale (with a score ≥10 clinically relevant anxiety). Patients with and without anxiety were compared regarding socio-demographic and clinical variables.</p><p><strong>Results: </strong>The sample (n = 136) had a median age of 59years (Q<sub>1</sub>: 49; Q<sub>3</sub>: 68), 66.2% were male and 31.6% presented clinically relevant anxiety. A higher percentage of HF patients with anxiety had psychiatric disorders (58.1% vs 26.9%; <i>P</i> = .001), psychotropic medication (62.8% vs 30.1%; <i>P</i> = .001), and depression (60.5% vs 9.7%; <i>P</i>< .001). No significant differences were found regarding the remaining variables, including NYHA classes.</p><p><strong>Conclusions: </strong>A substantial proportion of HF patients present clinically relevant anxiety, particularly those with psychiatric history, depressive symptoms, or under psychotropic medication. Therefore, integrating routine screening and treatment of this comorbidity in clinical practice is of utmost importance. Further studies are needed to clarify the association of anxiety with HF.</p>","PeriodicalId":74479,"journal":{"name":"Porto biomedical journal","volume":" ","pages":"e177"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521754/pdf/","citationCount":"1","resultStr":"{\"title\":\"Anxiety in heart failure patients and its association with socio-demographic and clinical characteristics: a cross-sectional study.\",\"authors\":\"Filipa M D Costa, Sónia P V Martins, Emilia C T D Moreira, José C M S Cardoso, Lia P N S Fernandes\",\"doi\":\"10.1097/j.pbj.0000000000000177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Anxiety is one of the most frequent psychiatric disorders in heart failure (HF) patients. However, it is often neglected in clinical practice and studies about the particular relationship with the New York Heart Association (NYHA) classes for HF are scarce. In this context, this study aims to analyze the presence of anxiety symptoms in HF outpatients and also its association with sociodemographic and clinical characteristics of these patients.</p><p><strong>Methods: </strong>This cross-sectional study is part of the longitudinal Deus Ex-Machina project (NORTE-01-0145-FEDER-000026). HF patients were recruited at an outpatient clinic at a University Hospital. Patients with inability to communicate, severe visual/hearing impairment, or NYHA class IV were excluded. Sociodemographic data and NYHA class were registered. Anxiety was assessed with the 7-item Generalized Anxiety Disorders Scale (with a score ≥10 clinically relevant anxiety). Patients with and without anxiety were compared regarding socio-demographic and clinical variables.</p><p><strong>Results: </strong>The sample (n = 136) had a median age of 59years (Q<sub>1</sub>: 49; Q<sub>3</sub>: 68), 66.2% were male and 31.6% presented clinically relevant anxiety. A higher percentage of HF patients with anxiety had psychiatric disorders (58.1% vs 26.9%; <i>P</i> = .001), psychotropic medication (62.8% vs 30.1%; <i>P</i> = .001), and depression (60.5% vs 9.7%; <i>P</i>< .001). No significant differences were found regarding the remaining variables, including NYHA classes.</p><p><strong>Conclusions: </strong>A substantial proportion of HF patients present clinically relevant anxiety, particularly those with psychiatric history, depressive symptoms, or under psychotropic medication. Therefore, integrating routine screening and treatment of this comorbidity in clinical practice is of utmost importance. Further studies are needed to clarify the association of anxiety with HF.</p>\",\"PeriodicalId\":74479,\"journal\":{\"name\":\"Porto biomedical journal\",\"volume\":\" \",\"pages\":\"e177\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521754/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Porto biomedical journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/j.pbj.0000000000000177\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Porto biomedical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/j.pbj.0000000000000177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
焦虑是心力衰竭(HF)患者最常见的精神障碍之一。然而,它在临床实践中经常被忽视,关于HF与纽约心脏协会(NYHA)课程的特殊关系的研究很少。在此背景下,本研究旨在分析心衰门诊患者焦虑症状的存在及其与这些患者的社会人口学和临床特征的关系。方法:本横断面研究是纵向《机械魔方》项目(norte -01-0145- federal -000026)的一部分。心衰患者在某大学医院的门诊招募。排除了无法沟通、严重视觉/听力障碍或NYHA IV级的患者。登记社会人口统计数据和NYHA班级。采用7项广泛性焦虑障碍量表评估焦虑(临床相关焦虑评分≥10分)。在社会人口学和临床变量方面比较有焦虑和没有焦虑的患者。结果:样本(n = 136)的中位年龄为59岁(Q1: 49;Q3: 68), 66.2%为男性,31.6%为临床相关焦虑。合并焦虑的心衰患者有精神障碍的比例较高(58.1% vs 26.9%;P = .001),精神药物(62.8% vs 30.1%;P = .001),抑郁症(60.5% vs 9.7%;P <措施)。其余变量(包括NYHA类别)没有发现显著差异。结论:相当比例的心衰患者存在临床相关的焦虑,特别是那些有精神病史、抑郁症状或正在服用精神药物的患者。因此,在临床实践中,将这种合并症的常规筛查和治疗结合起来是至关重要的。需要进一步的研究来阐明焦虑与心衰的关系。
Anxiety in heart failure patients and its association with socio-demographic and clinical characteristics: a cross-sectional study.
Anxiety is one of the most frequent psychiatric disorders in heart failure (HF) patients. However, it is often neglected in clinical practice and studies about the particular relationship with the New York Heart Association (NYHA) classes for HF are scarce. In this context, this study aims to analyze the presence of anxiety symptoms in HF outpatients and also its association with sociodemographic and clinical characteristics of these patients.
Methods: This cross-sectional study is part of the longitudinal Deus Ex-Machina project (NORTE-01-0145-FEDER-000026). HF patients were recruited at an outpatient clinic at a University Hospital. Patients with inability to communicate, severe visual/hearing impairment, or NYHA class IV were excluded. Sociodemographic data and NYHA class were registered. Anxiety was assessed with the 7-item Generalized Anxiety Disorders Scale (with a score ≥10 clinically relevant anxiety). Patients with and without anxiety were compared regarding socio-demographic and clinical variables.
Results: The sample (n = 136) had a median age of 59years (Q1: 49; Q3: 68), 66.2% were male and 31.6% presented clinically relevant anxiety. A higher percentage of HF patients with anxiety had psychiatric disorders (58.1% vs 26.9%; P = .001), psychotropic medication (62.8% vs 30.1%; P = .001), and depression (60.5% vs 9.7%; P< .001). No significant differences were found regarding the remaining variables, including NYHA classes.
Conclusions: A substantial proportion of HF patients present clinically relevant anxiety, particularly those with psychiatric history, depressive symptoms, or under psychotropic medication. Therefore, integrating routine screening and treatment of this comorbidity in clinical practice is of utmost importance. Further studies are needed to clarify the association of anxiety with HF.